New Data Reveals that 70 Percent of Online CBD Products are Inaccurate
Nowadays, thanks to the internet and the enormous e-commerce market that exists, CBD products can be sold on various websites and online stores rather than just in retail marijuana dispensaries. For those who live in a region where marijuana and/or CBD is illegal, online stores are the next best option. However, a 2017 study was conducted by the Journal of American Medical Association, which found that nearly 70 percent of cannabidiol (CBD) online products were either over or under-labeled, which can cause harm to consumers. Read on to learn more about this issue and why you should be extra careful when purchasing online CBD products.
Background of the Journal of American Medical Association Study (JAMA):
The study that was briefly mentioned above was conducted at the University of Pennsylvania Perelman School of Medicine by Marcel Bonn-Miller—lead author and an adjunct assistant professor of Psychology in Psychiatry and Dr. Jahan Marcu—Chief Scientific Officer for Americans for Safe Access & board member of the International Association for Cannabinoids as Medicine.
Journal of American Medical Association Study Findings:
In this research process, the team selected and purchased 84 CBD products that were available to purchase online from 31 different companies. These products consisted of various spanning oils, alcohol tinctures, and vaporization liquids. The findings were overwhelming, especially because inaccurately labeled CBD products were the majority.
Furthermore, after the researchers received their 84 CBD products, they removed the labels and replaced them with blinded study identifiers and proceeded to send them off to be tested by an independent lab. All products were analyzed three times to find the correct cannabinoid content, as mentioned by a SELF article on CBD products’ efficacy.
After testing all 84 products, 26 were accurately labeled while 36 products contained more CBD than what was shown on the label, and 22 contained less CBD than what the label displayed, according to the Journal of American Medical Association Study (JAMA). CBD products that were dubbed as being ‘accurately labeled’ contained 90-110 percent of the labeled value of CBD, whereas CBD products that were dubbed as being ‘under-labeled’ contained more than 110 percent. Then, the ‘over-labeled’ CBD products contained less than 90 percent CBD, as stated in the same study.
Also, out of the 84 tested products, around 21 percent contained THC with concentrations as high as 6.43 milligrams per milliliter, as stated by JAMA. This poses many safety concerns, especially because this amount could be enough to intoxicate a child. It’s safe to say that this issue of inaccurately labeled CBD products poses significant risks, and changes must be implemented to ensure that all CBD products are properly tested, analyzed, and correctly labeled.
How Inaccurate CBD Labels Could be Detrimental to Consumers:
Overall, the products that contained less CBD than what was shown on the label can be detrimental to consumers’ health. As a result, consumers may not receive the correct amount they need to experience the potential health benefits they would normally expect to receive.
These figures may surprise you, but to certain medical professionals and researchers, it’s expected due to the lack of extensive testing, regulation, and oversight of CBD products.
Bonn-Miller stated the following about this matter, “The biggest implication of the study is that many of these patients may not be getting the proper dosage; they’re either not getting enough for it to be effective or they’re getting too much.” This is a valid point.
Reasons for Mislabeled CBD Products:
In the JAMA study, researchers expressed that the findings highlight the dire need for both manufacturing and testing standards in addition to oversight of all medicinal cannabis products, especially CBD products. In a MedicalXPress article, Bonn-Miller made it clear to reporters that he believes the mislabeling issue is a direct result of inadequate regulation and oversight.
Unfortunately, the DEA classifies CBD as a Schedule I controlled substance regardless of multiple studies, trials, and research that demonstrate the benefits of CBD and cannabis overall.
As Bonn-Miller mentioned, currently, there aren’t any standards for producing, testing, or labeling various CBD oils and other products, which explains why there’s so many inaccurately labeled CBD products. In general, JAMA researchers suggest that CBD extract companies/sellers must implement better quality control and regulatory oversight. As a result, customers will know that they’re receiving the correct amount they believe they’re getting.
Overall, this mislabeling issue has sparked lots of concerns and worries amongst CBD users. To prevent this from happening in the future, standard regulations, testing, and oversight should be required and implemented throughout the cannabis and CBD industry. In the meantime, more people need to be aware of how many inaccurately labeled CBD products are being sold so we can collectively encourage regulation within this rapidly growing market.
Where to go from Here?
Fortunately, CBD legality is spreading within the U.S., and in particular, 44 states legally allow CBD. However, the DEA hasn’t removed it from its Schedule I classification. Regardless, consumers who purchase CBD products online should proceed with extreme caution unless they’re certain that the products have been fully tested and properly labeled.
If you’re looking for quality CBD products that you can purchase online, check out Infinite CBD’s line of properly tested and accurately labeled products. You deserve to try CBD without having to worry if you purchased an inaccurately labeled CBD product(s), so check out Infinite CBD today!